Optimization of liposomal topotecan for use in treating neuroblastoma-Reference-Cited by-同舟云学术

Optimization of liposomal topotecan for use in treating neuroblastoma

Published:2017-05-23 Issue:6 Volume:6 Page:1240-1254
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chernov Lina¹²,Deyell Rebecca J.³⁴,Anantha Malathi¹,Dos Santos Nancy¹,Gilabert-Oriol Roger¹^ORCID,Bally Marcel B.¹²⁵⁶

Affiliation:

1. Experimental Therapeutics; BC Cancer Agency; 675 West 10 Avenue Vancouver British Columbia V5Z 1L3 Canada

2. Department of Pathology and Laboratory Medicine; University of British Columbia; 2211 Wesbrook Mall Vancouver British Columbia V6T 2B5 Canada

3. Division of Pediatric Hematology/Oncology; British Columbia Children's Hospital and the University of British Columbia; 4480 Oak Street Vancouver British Columbia V6H 3V4 Canada

4. Michael Cuccione Childhood Cancer Research Program; British Columbia Children's Hospital Research Institute; 950 West 28 Avenue Vancouver British Columbia V5Z 4H4 Canada

5. Faculty of Pharmaceutical Sciences; University of British Columbia; 2405 Wesbrook Mall Vancouver British Columbia V6T 1Z3 Canada

6. Centre for Drug Research and Development; 4-2405 Wesbrook Mall Vancouver British Columbia V6T 1Z3 Canada

Funder

Canadian Institutes of Health Research

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference48 articles.

1. Neuroblastoma: developmental biology, cancer genomics and immunotherapy;Cheung;Nat. Rev. Cancer,2013

2. Neuroblastoma;Maris;Lancet,2007